Montelukast Sodium TCI M2340

Montelukast Sodium TCI M2340, with CAS number 151767-02-1, is a chemical compound widely used in life science research. It belongs to the category of enzyme inhibitors and plays a crucial role in biochemical studies related to immunology and respiratory systems. This compound is essential for investigating the mechanisms of allergic reactions and asthma, making it a valuable tool for researchers aiming to develop therapeutic interventions. Its stability under controlled conditions ensures consistent performance in laboratory experiments, supporting reliable and reproducible results.

The unique molecular structure of Montelukast Sodium allows it to interact specifically with leukotriene receptors, making it a preferred choice for pharmacological and immunological studies. Its ability to block these receptors is a key factor in its effectiveness for studying inflammatory responses and respiratory diseases. The compound's chemical stability and predictable behavior under various experimental conditions further enhance its reliability in laboratory settings, ensuring accurate data collection and analysis.

In Indonesian laboratories, Montelukast Sodium is commonly used to support research in public health and pharmaceutical sciences. It is a key component in studies focused on the treatment of allergic conditions and respiratory disorders. Many research institutions in Indonesia rely on this compound to advance their understanding of disease mechanisms and to develop new therapeutic strategies. Its widespread use highlights its importance in both academic and applied research environments.

• Used in immunology research to study the effects of leukotriene receptor antagonists on inflammatory responses.
• Applied in respiratory disease studies to evaluate the efficacy of Montelukast Sodium in reducing bronchoconstriction and airway inflammation.
• Utilized in pharmacological experiments to assess the compound's ability to modulate signaling pathways involved in allergic reactions.
• Employed in biochemical assays to test the inhibitory activity of Montelukast Sodium against specific enzymes.
• Integrated into drug development programs to explore its potential as a therapeutic agent for asthma and allergic disorders.

Montelukast Sodium should be stored in a cool, dry place, away from moisture and direct light to maintain its chemical stability. It is recommended to use airtight containers to prevent exposure to humidity, which could lead to degradation. In laboratory settings, it should be handled with appropriate personal protective equipment to ensure safety. While no specific physical form is provided, it is generally expected to be in a solid or crystalline form. Proper labeling and storage conditions are essential to maintain the integrity of the compound during research applications. Always follow standard laboratory safety protocols when working with biochemical reagents to ensure a safe and effective research environment.

—